Astrana Health, Inc. (ASTH) shareholders
Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 6,234,446 | 12.40% | 13G (passive) amendment | Mar 31, 2025 |
| Allied Physicians of California, a Professional Medical Corporation | 6,132,802 | 11.00% | 13D (active) amendment | Feb 15, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ASTH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,899,990 | 12.38% | $320.23M | +736,263 | 0.00% |
| Vanguard Portfolio Management LLC | 2,605,775 | 4.68% | $120.93M | +328,969 | 0.01% |
| Vanguard Capital Management LLC | 1,946,431 | 3.49% | $90.33M | +236,169 | 0.00% |
| State Street Corp | 1,738,930 | 3.12% | $80.70M | +88,440 | 0.00% |
| 325 Capital LLC | 1,613,843 | 2.90% | $74.90M | −225,233 | 17.85% |
| Dimensional Fund Advisors LP | 1,468,508 | 2.63% | $68.15M | +100,429 | 0.01% |
| Wellington Management Group Llp | 1,292,573 | 2.32% | $59.99M | −49,251 | 0.01% |
| Geode Capital Management, LLC | 1,167,974 | 2.10% | $54.22M | +129,889 | 0.00% |
| Bank Of America Corp /De/ | 852,145 | 1.53% | $39.55M | +277,416 | 0.00% |
| FMR LLC | 685,922 | 1.23% | $31.83M | +269,797 | 0.00% |
| Wells Fargo & Company/Mn | 664,940 | 1.19% | $30.86M | +561,941 | 0.00% |
| Charles Schwab Investment Management Inc | 652,669 | 1.17% | $30.29M | +8,498 | 0.00% |
| Ameriprise Financial Inc | 512,110 | 0.92% | $23.77M | −39,489 | 0.00% |
| Northern Trust Corp | 505,044 | 0.91% | $23.44M | +66,881 | 0.00% |
| Diamond Hill Capital Management Inc | 475,941 | 0.85% | $22.09M | −68,093 | 0.18% |
| Royce & Associates LP | 472,480 | 0.85% | $21.93M | +75,519 | 0.18% |
| SteelPeak Wealth, LLC | 464,937 | 0.83% | $21.58M | −95,000 | 0.56% |
| Morgan Stanley | 433,508 | 0.78% | $20.12M | +94,705 | 0.00% |
| Invesco Ltd. | 381,830 | 0.69% | $17.72M | +30,718 | 0.00% |
| Vanguard Fiduciary Trust Co | 307,022 | 0.55% | $14.25M | +14,019 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 209 | 32M | 57.7% | 58 / 81 | 49 / 17 | 5M | 3M |
| Q1 2026 | 171 | 30M | 53.7% | 27 / 64 | 54 / 28 | 7M | 2M |
| Q4 2025 | 176 | 29M | 52.3% | 38 / 56 | 66 / 43 | 4M | 2M |
| Q3 2025 | 188 | 27M | 48.1% | 48 / 65 | 56 / 21 | 3M | 2M |
| Q2 2025 | 162 | 26M | 46.8% | 32 / 53 | 55 / 35 | 2M | 2M |
| Q1 2025 | 168 | 26M | 47.0% | 21 / 58 | 59 / 31 | 2M | 2M |
| Q4 2024 | 179 | 26M | 46.8% | 31 / 68 | 54 / 41 | 3M | 2M |
| Q3 2024 | 189 | 25M | 45.5% | 32 / 69 | 58 / 14 | 10M | 1M |
| Q2 2024 | 172 | 23M | 41.5% | 30 / 64 | 48 / 15 | 2M | 2M |
| Q1 2024 | 159 | 24M | 42.3% | 28 / 50 | 51 / 12 | 1M | 1M |
| Q4 2023 | 143 | 23M | 40.7% | 22 / 47 | 51 / 12 | 2M | 1M |
| Q3 2023 | 134 | 22M | 38.6% | 16 / 52 | 46 / 12 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
216 funds held ASTH in Q2 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ASTH | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2,558,015 | 4.59% | $118.72M | 0.11% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,416,817 | 2.54% | $65.75M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,186,705 | 2.13% | $55.07M | 0.07% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,021,229 | 1.83% | $47.40M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 591,784 | 1.06% | $27.46M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 499,026 | 0.90% | $17.75M | 0.05% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 487,318 | 0.87% | $22.62M | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 421,171 | 0.76% | $19.55M | 0.13% | Jun 30, 2026 |
| Diamond Hill Small Cap Fund | 411,996 | 0.74% | $19.12M | 6.21% | Jun 30, 2026 |
| Select Health Care Services Portfolio | 397,590 | 0.71% | $14.96M | 1.85% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 390,080 | 0.70% | $18.10M | 0.11% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 365,485 | 0.66% | $16.96M | 0.21% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 318,530 | 0.57% | $11.33M | 0.13% | Jul 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 303,692 | 0.54% | $14.09M | 0.12% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 223,583 | 0.40% | $8.41M | 0.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kenneth T. Sim | Executive Chairman, Director | 7,692,242 | 13.80% | Apr 8, 2026 |
| John Vong | SVP - Accounting (PAO) | 21,132 | 0.04% | Nov 13, 2026 |
| Brandon Sim | CEO and President | 1,880,612 | 3.37% | Oct 8, 2026 |
| Chandan Basho | COO and CFO | 155,728 | 0.28% | Oct 6, 2026 |
| Dinesh M. Kumar | Chief Medical Officer | 177,655 | 0.32% | Apr 3, 2026 |
| Thomas S. Lam | Director | 7,729,541 | 13.87% | Oct 8, 2026 |
| Mitchell W. Kitayama | Director | 24,337 | 0.04% | Sep 1, 2026 |
| David Schmidt | Director | 56,019 | 0.10% | Aug 18, 2026 |
| John Chiang | Director | 35,373 | 0.06% | Jun 12, 2026 |
| Linda Dong | Director | 97,133 | 0.17% | Jun 12, 2026 |
| Matthew Mazdyasni | Director | 39,288 | 0.07% | Jun 12, 2026 |
| Dai, Weili | Director | 18,188 | 0.03% | Jun 12, 2026 |
| Glenn Sobotka | – | 2,246 | 0.00% | Aug 11, 2026 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 10% owner | 6,132,802 | 11.00% | Feb 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John Vong SVP - Accounting (PAO) | Nov 12, 2026 | Tax withholding | −642 | $31.77 | $20.40K | 21,132 |
| John Vong SVP - Accounting (PAO) | Oct 10, 2026 | Tax withholding | −556 | $37.55 | $20.88K | 21,774 |
| Brandon Sim CEO and President | Oct 6, 2026 | Tax withholding | −9,889 | $37.00 | $365.89K | 1,228,972 |
| Thomas S. Lam Director | Oct 6, 2026 | Tax withholding | −2,624 | $37.00 | $97.09K | 463,033 |
| Chandan Basho COO and CFO | Oct 2, 2026 | Tax withholding | −2,092 | $35.88 | $75.06K | 155,728 |
| John Vong SVP - Accounting (PAO) | Sep 15, 2026 | Tax withholding | −96 | $38.35 | $3.68K | 22,330 |
| Brandon Sim CEO and President | Sep 5, 2026 | Tax withholding | −7,163 | $38.47 | $275.56K | 1,238,861 |
| Chandan Basho COO and CFO | Sep 5, 2026 | Tax withholding | −1,790 | $38.47 | $68.86K | 157,820 |
| Mitchell W. Kitayama Director | Aug 31, 2026 | Returned to company | −8,500 | $37.09 | $315.27K | 24,337 |
| David Schmidt Director | Aug 14, 2026 | Option exercise | +20,000 | $5.00 | $100.00K | 56,019 |
| David Schmidt Director | Aug 14, 2026 | Returned to company | −20,000 | $38.59 | $771.80K | 36,019 |
| Glenn Sobotka – | Aug 7, 2026 | Returned to company | −11,793 | – | – | 2,246 |
| Brandon Sim CEO and President | Jun 27, 2026 | Tax withholding | −1,093 | $44.51 | $48.65K | 1,245,292 |
| David Schmidt Director | Jun 10, 2026 | Award | +4,525 | – | – | 36,019 |
| Dai, Weili Director | Jun 10, 2026 | Award | +4,525 | – | – | 18,188 |
| Matthew Mazdyasni Director | Jun 10, 2026 | Award | +4,525 | – | – | 39,288 |
| Mitchell W. Kitayama Director | Jun 10, 2026 | Award | +4,991 | – | – | 32,837 |
| John Chiang Director | Jun 10, 2026 | Award | +4,525 | – | – | 35,373 |
| Linda Dong Director | Jun 10, 2026 | Award | +4,525 | – | – | 97,133 |
| Chandan Basho COO and CFO | May 16, 2026 | Tax withholding | −8,155 | $38.26 | $312.01K | 159,610 |
| Chandan Basho COO and CFO | Apr 14, 2026 | Tax withholding | −3,870 | $29.07 | $112.50K | 167,765 |
| Kenneth T. Sim Executive Chairman, Director | Apr 6, 2026 | Award | +100,000 | – | – | 739,407 |
| Brandon Sim CEO and President | Apr 6, 2026 | Award | +201,056 | – | – | 1,246,385 |
| Thomas S. Lam Director | Apr 6, 2026 | Award | +41,667 | – | – | 465,657 |
| Chandan Basho COO and CFO | Apr 2, 2026 | Tax withholding | −2,092 | $25.05 | $52.40K | 171,635 |
| Dinesh M. Kumar Chief Medical Officer | Apr 1, 2026 | Tax withholding | −57,980 | $24.51 | $1.42M | 177,655 |
| Dinesh M. Kumar Chief Medical Officer | Apr 1, 2026 | Award | +35,300 | – | – | 235,635 |
| Glenn Sobotka Chief Accounting Officer | Mar 26, 2026 | Tax withholding | −662 | $24.27 | $16.07K | 14,039 |
| Dinesh M. Kumar Chief Medical Officer | Mar 5, 2026 | Tax withholding | −1,697 | $25.07 | $42.54K | 200,335 |
| Chandan Basho COO and CFO | Mar 5, 2026 | Tax withholding | −1,240 | $25.07 | $31.09K | 173,727 |
| Thomas S. Lam Director | Mar 5, 2026 | Tax withholding | −9,266 | $25.07 | $232.30K | 423,990 |
| Brandon Sim CEO and President | Feb 2, 2026 | Option exercise | +21,334 | $23.24 | $495.80K | 1,045,329 |
| Dinesh M. Kumar Chief Medical Officer | Jan 23, 2026 | Tax withholding | −10,759 | $27.16 | $292.21K | 202,032 |
| David Schmidt Director | Jan 13, 2026 | Option exercise | +20,000 | $5.79 | $115.80K | 35,763 |
| David Schmidt Director | Jan 13, 2026 | Tax withholding | −4,269 | $27.12 | $115.78K | 31,494 |
| Dinesh M. Kumar Chief Medical Officer | Jan 1, 2026 | Tax withholding | −5,102 | $24.81 | $126.58K | 212,791 |
| Thomas S. Lam Director | Dec 8, 2025 | Tax withholding | −25,866 | $22.00 | $569.05K | 433,256 |
| Thomas S. Lam Director | Dec 8, 2025 | Option exercise | +29,502 | $17.78 | $524.55K | 459,122 |
| Kenneth T. Sim Executive Chairman, Director | Nov 10, 2025 | Option exercise | +29,502 | $17.78 | $524.55K | 639,407 |
| Matthew Mazdyasni Director | Nov 10, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 34,763 |
| Mitchell W. Kitayama Director | Nov 7, 2025 | Option exercise | +12,000 | $18.20 | $218.40K | 27,846 |
| Linda Dong Director | Nov 3, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 103,641 |
| Linda Dong Director | Nov 3, 2025 | Tax withholding | −11,033 | $32.99 | $363.98K | 92,608 |
| Chandan Basho COO and CFO | Oct 2, 2025 | Tax withholding | −1,979 | $27.77 | $54.96K | 174,967 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Returned to company | −5,214 | $30.23 | $157.62K | 15,846 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Returned to company | −8,000 | $30.23 | $241.84K | 21,060 |
| Mitchell W. Kitayama Director | Sep 15, 2025 | Option exercise | +8,000 | $18.20 | $145.60K | 29,060 |
| Chandan Basho COO and CFO | Sep 5, 2025 | Tax withholding | −1,694 | $29.70 | $50.31K | 176,946 |
| Dinesh M. Kumar Chief Medical Officer | Sep 5, 2025 | Tax withholding | −1,694 | $29.70 | $50.31K | 217,893 |
| David Schmidt Director | Sep 2, 2025 | Returned to company | −20,000 | $27.76 | $555.20K | 15,763 |
| David Schmidt Director | Sep 2, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 35,763 |
| John Chiang Director | Aug 13, 2025 | Option exercise | +20,000 | $18.20 | $364.00K | 43,132 |
| John Chiang Director | Aug 13, 2025 | Tax withholding | −12,284 | $29.63 | $363.97K | 30,848 |
| Dinesh M. Kumar Chief Medical Officer | Jul 1, 2025 | Tax withholding | −6,831 | $25.06 | $171.18K | 218,811 |
| Linda Dong Director | Jun 11, 2025 | Award | +6,449 | – | – | 83,641 |
| David Schmidt Director | Jun 11, 2025 | Award | +6,449 | – | – | 15,763 |
| John Chiang Director | Jun 11, 2025 | Award | +6,449 | – | – | 23,132 |
| Mitchell W. Kitayama Director | Jun 11, 2025 | Award | +6,449 | – | – | 21,060 |
| Dai, Weili Director | Jun 11, 2025 | Award | +6,449 | – | – | 13,663 |
| Matthew Mazdyasni Director | Jun 11, 2025 | Award | +6,449 | – | – | 14,763 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Astrana Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 30,861 shares on Sep 16, 2026 over the last 90 days.
See a number that looks wrong?